0

512600

ASTALLTD

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ASTAL LABORATORIES LIMITED Share Price Today

Investment Returns

Over 1 Month 8.09% Over 3 Months 6.34% Over 6 Months -13.63% Over 1 Year -2.44%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ASTAL LABORATORIES LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 348.20
  • P/E Ratio (TTM) 41.89
  • Beta 0.32
  • Book Value / share 76.13
  • Return on equity 30.10%
  • EPS (TTM) 1.85
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 1.09
info icon alternate text

ASTAL LABORATORIES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 40.92
Operating Expense 39.51
Net Profit 1.09
Net Profit Margin (%) 2.66
Earnings Per Share (EPS) 0.29
EBITDA 2.26
Effective Tax Rate (%) 26.53
Particulars DEC 2025 (Values in Cr)
Revenue 52.24
Operating Expense 49.14
Net Profit 2.36
Net Profit Margin (%) 4.51
Earnings Per Share (EPS) 2.19
EBITDA 3.58
Effective Tax Rate (%) 24.60
Particulars SEP 2025 (Values in Cr)
Revenue 37.52
Operating Expense 34.08
Net Profit 2.58
Net Profit Margin (%) 6.87
Earnings Per Share (EPS) 2.40
EBITDA 3.90
Effective Tax Rate (%) 25.64
Particulars JUN 2025 (Values in Cr)
Revenue 25.33
Operating Expense 22.59
Net Profit 2.09
Net Profit Margin (%) 8.25
Earnings Per Share (EPS) 2.13
EBITDA 3.21
Effective Tax Rate (%) 25.08
Particulars MAR 2025 (Values in Cr)
Revenue 23.47
Operating Expense 19.66
Net Profit 2.74
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 2.80
EBITDA 4.22
Effective Tax Rate (%) 28.57
Particulars MAR 2026 (Values in Cr)
Revenue 156.00
Operating Expense 145.32
Net Profit 8.12
Net Profit Margin (%) 5.20
Earnings Per Share (EPS) 4.76
EBITDA 12.96
Effective Tax Rate (%) 25.29
Particulars MAR 2025 (Values in Cr)
Revenue 64.23
Operating Expense 52.38
Net Profit 8.93
Net Profit Margin (%) 13.90
Earnings Per Share (EPS) 9.08
EBITDA 12.90
Effective Tax Rate (%) 25.45
Particulars MAR 2024 (Values in Cr)
Revenue 23.65
Operating Expense 22.57
Net Profit 0.78
Net Profit Margin (%) 3.29
Earnings Per Share (EPS) 0.80
EBITDA 1.13
Effective Tax Rate (%) 27.52
Particulars MAR 2023 (Values in Cr)
Revenue 3.43
Operating Expense 3.57
Net Profit 0.02
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 0.04
EBITDA 0.04
Effective Tax Rate (%) 66.66
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.23
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.77
ROE % 30.10
ROCE % 34.78
Total Debt to Total Equity 0.23
EBITDA Margin 20.08
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.71
ROE % 5.47
ROCE % 7.56
Total Debt to Total Equity 0.01
EBITDA Margin 4.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.98
ROE % 0.39
ROCE % 0.77
Total Debt to Total Equity 0.00
EBITDA Margin 1.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.93
ROE % -0.39
ROCE % -0.19
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.97
ROE % 0.19
ROCE % 0.19
Total Debt to Total Equity 0.00
EBITDA Margin 10.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 63.34
Total Liabilities 63.34
Total Equity 35.99
Share Outstanding 0
Price to Book Ratio 2.32
Return on Assets (%) 14.09
Return on Capital (%) 18.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.07
Total Assets 36.61
Total Liabilities 36.61
Total Equity 23.33
Share Outstanding 0
Price to Book Ratio 1.72
Return on Assets (%) 2.14
Return on Capital (%) 3.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 9.90
Total Liabilities 9.90
Total Equity 5.17
Share Outstanding 0
Price to Book Ratio 2.28
Return on Assets (%) 0.16
Return on Capital (%) 0.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.22
Total Liabilities 5.22
Total Equity 5.16
Share Outstanding 0
Price to Book Ratio 1.25
Return on Assets (%) -0.32
Return on Capital (%) -0.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 5.30
Total Liabilities 5.30
Total Equity 5.17
Share Outstanding 0
Price to Book Ratio 0.67
Return on Assets (%) 0.11
Return on Capital (%) 0.12
Particulars MAR 2025 (Values in Cr)
Net Income 11.97
Cash from Operations -12.21
Cash from Investing -7.81
Cash from Financing 3.29
Net change in Cash -17.04
Free Cash Flow -6.44
Particulars MAR 2024 (Values in Cr)
Net Income 1.08
Cash from Operations -5.54
Cash from Investing -6.10
Cash from Financing 17.67
Net change in Cash 5.99
Free Cash Flow 0.36
Particulars MAR 2023 (Values in Cr)
Net Income 0.03
Cash from Operations -1.42
Cash from Investing 1.50
Cash from Financing 0.00
Net change in Cash 0.06
Free Cash Flow -1.42
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations -0.24
Cash from Investing 0.23
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.24
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations -0.18
Cash from Investing 0.20
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow -0.18
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.82 13.15 1.53 243.85 23.12 38.85
BLISS GVS PHARMA LTD. 469.40 38.10 4.17 4978.28 118.35 493.70
CIPLA LTD. 1433.10 30.41 3.36 115772.31 1165.55 1672.20
FERMENTA BIOTECH LIMITED 351.75 15.52 2.54 1035.23 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.82 22.25 4.09 243.85 23.12 38.85
AMRUTAJAN HEALTH LTD 552.95 24.78 4.31 1598.61 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8503.30 111.05 24.35 21258.25 7630.00 9850.00
BLISS GVS PHARMA LTD. 469.40 50.64 4.30 4978.28 118.35 493.70

ASTAL LABORATORIES LIMITED shareholding pattern

Holding
95.46%
4.53%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ASTAL LABORATORIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
79.51 2.60 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 79.90
  • 26 Days 76.50
  • 10 Days 79.10
  • 50 Days 75.00
  • 12 Days 78.70
  • 100 Days 75.90
  • 20 Days 77.20
  • 200 Days 79.00
78.87 PIVOT
First Support 75.73 First Resistance 80.62 Second Support 73.98 Second Resistance 83.76 Third Support 70.84 Third Resistance 85.51
RSI 52.06 ADX 22.35 MACD 2.19 Williams % R -36.80 Commodity Channel Index (CCI) 50.57
Date 2026-06-23 Week 20346.00 Same Day 22066.00 Month 22057.00
1 Year 0.32 3 Year 0.27
Over 1 Month
8.09% down
Over 1 Year
-2.44% down
Over 3 Months
6.34% down
Over 3 Years
36.57% down
Over 6 Months
-13.63% down
Over 5 Years
53.30% down

ASTAL LABORATORIES LIMITED Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Astal Laboratories Ltd?

Answer Field

Astal Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 79.51 as on Jun 24 2026 03:30 PM.

What is the Market Cap of Astal Laboratories Ltd Share?

Answer Field

The market cap of Astal Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 348.20 as on Jun 24 2026 03:30 PM.

What is the 52 Week High and Low of Astal Laboratories Ltd?

Answer Field

The 52 Week High and Low of Astal Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 103.20 and ₹ 60.45.

What is 1 year return for Astal Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -2.44%.

What is the P/E Ratio of Astal Laboratories Ltd Share?

Answer Field

As on Jun 24 2026 03:30 PM the price-to-earnings (PE) ratio for Astal Laboratories Ltd share is 41.89.

What is the PB ratio of Astal Laboratories Ltd Share?

Answer Field

As on Jun 24 2026 03:30 PM, the price-to-book (PB) ratio for Astal Laboratories Ltd share is 76.13.

How to Buy Astal Laboratories Ltd Share?

Answer Field

You can trade in Astal Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Astal Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Astal Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Astal Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|